Yüklüyor......
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
OBJECTIVE: To evaluate the efficacy and safety of ultra rapid lispro (URLi) versus lispro in patients with type 2 diabetes on a basal-bolus insulin regimen. RESEARCH DESIGN AND METHODS: This was a phase 3, treat-to-target, double-blind 26-week study. After an 8-week lead-in to optimize basal insulin...
Kaydedildi:
| Yayımlandı: | Diabetes Care |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Diabetes Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770265/ https://ncbi.nlm.nih.gov/pubmed/32616612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-2550 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|